TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Vicarious Surgical ( (RBOT) ) is now available.
On December 1, 2025, Beverly Huss and Randy Clark resigned from Vicarious Surgical‘s Board of Directors as part of a decision to reduce the board’s size from nine to seven members. This change did not stem from any disagreements with the company’s operations. Subsequently, Joseph Doherty, Fuad Ahmad, and Victoria Carr-Brendel were appointed to new roles within the board’s committees. On December 3, 2025, Vicarious Surgical announced an improved cash burn outlook for 2025, reducing it from $50 million to $45 million due to disciplined cost management. This financial update aligns with the company’s strategic focus on operational efficiency and supports its long-term goals.
The most recent analyst rating on (RBOT) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Underperform.
Vicarious Surgical’s stock score reflects significant financial challenges as a pre-revenue company with high cash burn, offset by a moderately stable balance sheet. Technical analysis indicates bearish sentiment, compounded by valuation challenges due to negative earnings. While the earnings call showed strategic advancements, supply chain delays and NYSE compliance issues pose risks. Successful clinical trials and improved cash management will be critical for future performance.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical, founded in 2014 and headquartered in Waltham, Massachusetts, is a next-generation robotics company focused on transforming robotic surgery. The company aims to enhance surgical efficiency, improve patient outcomes, and reduce healthcare costs through its proprietary human-like surgical robots that enable minimally invasive procedures. Vicarious Surgical is supported by notable investors including Bill Gates and Khosla Ventures.
Average Trading Volume: 84,044
Technical Sentiment Signal: Sell
Current Market Cap: $17.42M
See more data about RBOT stock on TipRanks’ Stock Analysis page.